Nutrition, Metabolism, and Cardiovascular Diseases · Nov 2026

Trends and Disparities in MASLD and Cardiovascular Disease Related Mortality in the United States

By Aisha E, Nadeem F, Batool RM et al.

Background and Aims Cardiovascular disease (CVD) is the leading cause of death among patients with metabolic dysfunction-associated steatotic liver disease (MASLD), yet national trends in MASLD and CVD related mortality and associated demographic and geographic disparities remain incompletely characterized. Methods and Results We conducted a retrospective analysis of mortality data from the CDC WONDER Multiple Cause of Death database. Adults aged 25 years and older were included. Deaths were identified when MASLD and CVD were listed as contributing causes on the same death certificate. Age-adjusted mortality rates (AAMR) per 1,000,000 persons were calculated and stratified by sex, race/ethnicity, census region, and urbanization level. Annual percent change (APC) and average annual percent change (AAPC) were estimated using Joinpoint regression. Between 1999 and 2020, 36,485 MASLD and CVD-related deaths were recorded. Overall, AAMR increased from 3.86 in 1999 to 10.22 in 2020, with an AAPC of 4.59% (95% CI: 3.77 to 5.58). Men had higher AAMRs than women. Non-Hispanic American Indian individuals had the highest AAMR (10.79) across racial groups. Geographically, the West reported the highest regional AAMR (7.91), and non-metropolitan areas exhibited slightly higher AAMR (5.18) than metropolitan areas (5.05). Over time, the proportion of deaths attributable to ischemic heart disease declined, whereas the proportional contributions of hypertensive heart disease, heart failure, and arrhythmia and conduction disorders increased. Conclusion MASLD and CVD related mortality among patients increased by more than 2.5-fold over two decades, with significant disparities across demographic and geographic subgroups, underscoring the need for targeted prevention strategies in high-risk populations. Lay summary Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to a rising number of cardiovascular disease–related deaths in the United States. From 1999 to 2020, these deaths increased substantially and were unevenly distributed, with higher rates among men, rural populations, non-Hispanic American Indian and White individuals, and those living in the Western United States. These findings highlight the need for earlier risk recognition and more targeted prevention efforts in the populations most affected.

doi.org/10.1016/j.numecd.2026.105074Populations

AgingResearch.News